These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1159416)

  • 1. On the synchronizing effect of amantadine-1-hydrochlorid (Symmetrel) on pathological EEG-activity.
    Vardi J; Streifler M
    J Neural Transm; 1975; 37(1):73-80. PubMed ID: 1159416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of amantadine (Viregyt-K) on extrapyramidal symptoms of parkinsonian patients.
    Boczán G
    Ther Hung; 1974; 22(4):147-53. PubMed ID: 4465958
    [No Abstract]   [Full Text] [Related]  

  • 3. Amantadine treatment of a patient with anoxic brain injury.
    Edby K; Larsson J; Eek M; von Wendt L; Ostergård B
    Childs Nerv Syst; 1995 Oct; 11(10):607-9. PubMed ID: 8556729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.
    Danysz W; Parsons CG; Kornhuber J; Schmidt WJ; Quack G
    Neurosci Biobehav Rev; 1997 Jul; 21(4):455-68. PubMed ID: 9195603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of Parkinsonian syndrome using amantadine hydrochloride].
    Schubert U; Fischer GJ; Glass J
    Z Arztl Fortbild (Jena); 1975 May; 69(9):469-76. PubMed ID: 1106004
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of the parkinsonian syndrome with L-dopa and amantadine].
    Pendefunda GH; Pollingher B; Stefanache F; Gavril A; Oprişan C; Merling M; Nemţeanu E; Ciuntu M; Koropitzer I
    Neurol Psihiatr Neurochir; 1973; 18(6):559-68. PubMed ID: 4790488
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Parkinson's disease with amantadine (Symmetrel).
    van Manen J
    Psychiatr Neurol Neurochir; 1972; 75(1):49-59. PubMed ID: 5024896
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of anti-parkinsonian drugs on the motor activity and EEG of cats with subthalamic lesions.
    Lindsley DF; Ranf SK; Fernandez FC; Wyrwicka W
    Exp Neurol; 1975 Jun; 47(3):404-18. PubMed ID: 1132456
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diverse seizures, unusual EEG seizure pattern and episodic organic brain syndrome. A case report].
    Müller D; Hallmeyer-Elgner S
    Nervenarzt; 2015 Jul; 86(7):887-90. PubMed ID: 25777133
    [No Abstract]   [Full Text] [Related]  

  • 10. [Edemas and myocloni concerning a patient with Parkinson's disease treated by amantadine (author's transl)].
    Chevalier JF; Renier E; Brion S
    Encephale; 1980; 6(4):381-4. PubMed ID: 7439114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual hallucinations and delirium during treatment with amantadine (Symmetrel).
    Postma JU; Van Tilburg W
    J Am Geriatr Soc; 1975 May; 23(5):212-5. PubMed ID: 123540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The additive effect of amantadine hydrochloride (Symmetrel) on parkinsonian patients receiving levodopa treatment (author's transl)].
    Shiozawa R; Kase M; Kuroiwa Y; Narabayashi H; Nishitani Y; Ohmoto T; Toyokura Y; Uono K
    No To Shinkei; 1981 Mar; 33(3):301-9. PubMed ID: 7018522
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of symmetrel (amantadine hydrochloride) on a case of athetosis.
    Hatchuel WL
    S Afr Med J; 1971 May; 45(18):499-500. PubMed ID: 4941206
    [No Abstract]   [Full Text] [Related]  

  • 14. [Functional brain activity in patients with Parkinson's disease during amantadin-sulfate therapy].
    Arakelian RK; Nerobkova LN; Katunina EA; Val'dman EA; Kapitsa IG; Voronina TA; Avakian GN; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(4):17-21. PubMed ID: 15875939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of amantadine on neuroleptic-induced parkinsonism.
    Rüther E; Fussmann-Hegewald M; Eben E
    Act Nerv Super (Praha); 1973 May; 15(2):93. PubMed ID: 4148089
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of tolerance to the therapeutic effect of amantadine on akathisia.
    Zubenko GS; Barreira P; Lipinski JF
    J Clin Psychopharmacol; 1984 Aug; 4(4):218-20. PubMed ID: 6470196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of L-dopa or amantadine treatment on the spindles of sleep in Parkinson's syndromes].
    Puca FM; Bricolo A; Turella G
    Rev Neurol (Paris); 1972 Aug; 127(2):313. PubMed ID: 4666639
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current treatment of the Parkinsonian syndrome].
    Voiculescu V
    Neurol Psihiatr Neurochir; 1973; 18(6):519-23. PubMed ID: 4790485
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of amantadine on drug-induced parkisonism: relationship between plasma levels and effect.
    Pacifici GM; Nardini M; Ferrari P; Latini R; Fieschi C; Morselli PL
    Br J Clin Pharmacol; 1976 Oct; 3(5):883-9. PubMed ID: 788761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.